search efforts of the National Institute of Mental Health, National Institute on Drug Abuse, National Institute on Alcohol Abuse and Alcoholism, Department of Veterans Affairs, Substance Abuse and Mental Health Services Administration, Agency for Healthcare Research and Quality, and Centers for Medicare and Medicaid Services, and it should develop and fund cross-agency efforts in necessary new research. To that end, the initiative should address the full range of research needed to reduce gaps in knowledge at the clinical, services, systems, and policy levels and should establish links to and encourage expanded efforts by foundations, states, and other nonfederal organizations.
Recommendation 9-2. Federal and state agencies and private foundations should create health services research strategies and innovative approaches that address treatment effectiveness and quality improvement in usual settings of care delivery. To that end, they should develop new research and demonstration funding models that encourage local innovation, that include research designs in addition to randomized controlled trials, that are committed to partnerships between researchers and stakeholders, and that create a critical mass of interdisciplinary research partnerships involving usual settings of care. Stakeholders should include consumers/patients, parents or guardians of children, clinicians and clinical teams, organization managers, purchasers, and policy makers.
AHRQ (Agency for Healthcare Research and Quality). 2003. National Healthcare Quality Report. Rockville, MD: U.S. Department of Health and Human Services.
Anthony WA. 1993. Recovery from mental illness: The guiding vision of the mental health service system in the 1990s. Psychological Rehabilitation Journal 16(4):11–24.
Bauer MS. 2002. A review of quantitative studies of adherence to mental health clinical practice guidelines. Harvard Review of Psychiatry 10(3):138–153.
Bergeson S. 2004. Testimony before the Institute of Medicine Workshop on Crossing the Quality Chasm: An Adaptation to Mental Health and Addictive Disorders. Washington, DC, July 14. Available from Institute of Medicine.
Buchanan RW, Kreyenbuhl J, Zito JM, Lehman A. 2002. The schizophrenia PORT pharmacological treatment recommendations: Conformance and implications for symptoms and functional outcome. Schizophrenia Bulletin 28(1):63–73.
Burns BJ, Phillips SD, Wagner R, Barth RP, Kolko DJ, Campbel Y, Landsverk J. 2004. Mental health need and access to mental health services by youths involved with child welfare: A national survey. Journal of the American Academy of Child and Adolescent Psychiatry 43(8):960–970.
Burton WN, Pransky G, Conti DJ, Chen C-Y, Edington DW. 2004. The association of medical conditions and presenteeism. Journal of Occupational and Environmental Medicine 46(6), Supplement:S38–S45.